
PAVmed PAVM
$ 9.0
-1.85%
Annual report 2025
added 03-27-2026
PAVmed Interest Expense 2011-2026 | PAVM
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense PAVmed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -10.5 M | -12.2 M | -1.73 M | -12.5 M | -2.97 M | 2.39 M | 725 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.39 M | -12.5 M | -5.25 M |
Quarterly Interest Expense PAVmed
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | -6.22 M | -1.41 M | -1.81 M | - | -6.56 M | -5.62 M | 2 K | - | -1.73 M | 300 K | -2.03 M | - | -346 K | -830 K | 52.5 K | - | -28 K | -420 K | -560 K | - | 708 K | 500 K | 500 K | - | 362 K | 1.03 M | 2.11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.11 M | -6.56 M | -1.05 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.22 | -2.57 % | $ 121 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 189.61 | -0.56 % | $ 14.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.8 | 0.55 % | $ 1.73 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.16 | 4.85 % | $ 1.31 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.19 | -0.12 % | $ 380 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.78 | 9.58 % | $ 334 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 64.2 | -1.45 % | $ 3.5 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.27 | -0.78 % | $ 51.7 M | ||
|
Electromed
ELMD
|
78 K | $ 26.39 | 3.57 % | $ 223 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 94.87 | 0.52 % | $ 12.8 B | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 12.35 | 1.65 % | $ 489 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 5.33 | 3.5 % | $ 1.13 B | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.84 | 1.88 % | $ 388 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 189.56 | -1.38 % | $ 13.3 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 38.34 | 2.24 % | $ 1.19 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 56.31 | -0.07 % | $ 1.65 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 86.02 | 1.37 % | $ 2.99 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 84.15 | 5.56 % | $ 49.2 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.09 | -3.23 % | $ 60.9 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.47 | -1.59 % | $ 6.85 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.43 | 2.39 % | $ 507 M |